Maia Pharmaceuticals, Inc.
Sincalide for Injection, a pharmaceutical therapeutic agent
- Sector
- Digital health
- Headquarters
- PRINCETON, NJ
- Founded
- 2013
- Latest Form D
- $845K, Nov 2014
- Total capital
- $845K
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $845K
- 1 Form D · last Nov 2014
- 144 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 11
- 10 pending · first 2021
- Rank in peer group#1 of 16
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$845K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 16 peers
Line = medianDigital health · Service
- Granted patents#1 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Srikanth SundaramResearcherExecutive Officer, DirectorLinked by 11 patents
- Brian LiptonDirectorNamed in SEC Form D filings
- Vishnukant BhutadaDirectorNamed in SEC Form D filings
What it has protected
USPTO · 11 granted of 21- PendingDaptomycin CompositionsUSPTOApplication 19301835
- GrantedReady-to-use Bivalirudin CompositionsUSPTOUS 12,472,224
- GrantedBortezomib CompositionsUSPTOUS 12,005,069
Show all 21 patent records
- Daptomycin CompositionsMay 21, 2026 · Application 19301835Pending
- Ready-to-use Bivalirudin CompositionsNov 18, 2025 · US 12,472,224Granted
- Bortezomib CompositionsJun 11, 2024 · US 12,005,069Granted
- Ready-to-use Bivalirudin CompositionsMay 28, 2024 · US 11,992,514Granted
- Ready-to-use Bivalirudin CompositionsMar 5, 2024 · US 11,918,622Granted
- Ready-to-use Bivalirudin CompositionsFeb 20, 2024 · US 11,903,993Granted
- Bortezomib CompositionsSep 12, 2023 · US 11,752,164Granted
- Storage Stable Sincalide FormulationsAug 29, 2023 · US 11,737,983Granted
- Bortezomib CompositionsJun 20, 2023 · US 11,679,119Granted
- Bortezomib CompositionsJun 13, 2023 · US 11,672,813Granted
- Bortezomib CompositionsApr 6, 2023 · Application 17934873Pending
- Bortezomib CompositionsMar 30, 2023 · Application 17934884Pending
- Storage Stable Sincalide FormulationsMay 3, 2022 · US 11,318,100Granted
- Storage Stable Sincalide FormulationsSep 7, 2021 · US 11,110,063Granted
- Storage Stable Sincalide FormulationsApplication 62550484Pending
- Daptomycin CompositionsApplication 63723325Pending
- Bortezomib CompositionsApplication PCTUS2022044537Pending
- Bortezomib CompositionsApplication 63248314Pending
- Ready-to-use Bivalirudin CompositionsApplication PCTUS2019033139Pending
- Storage Stable Sincalide FormulationsApplication PCTUS2018048004Pending
- Daptomycin CompositionsApplication PCTUS2025052069Pending
Related companies, and why
- Doc Buddy Inc.Similar federal contract value in Digital health · null in contracts
- PharmID, Inc.Similar federal contract value in Digital health · null in contracts
- Oncora Medical, Inc.Similar federal contract value in Digital health · null in contracts
- Tensor Black, Inc.Similar federal contract value in Digital health · null in contracts
- Longevix, Inc.Similar federal contract value in Digital health · null in contracts
- AiCare CorpSimilar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .